Tetraspanin CD151 as a target for antibody-based cancer immunotherapy

Biochemical Society Transactions

Volumn 39, Issue 2, 2011, Pages 553-558

  Haeuw, Jean François ^a   Goetsch, Liliane ^a   Bailly, Christian ^a   Corvaia, Nathalie ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Cancer immunotherapy; CD151; Tetraspanin; Therapeutic antibody

Indexed keywords

ANTINEOPLASTIC AGENT; CD151 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 11B1.G4; MONOCLONAL ANTIBODY 14A2.H1; MONOCLONAL ANTIBODY 1A5 6; MONOCLONAL ANTIBODY 50 6; MONOCLONAL ANTIBODY 8C3; MONOCLONAL ANTIBODY SFA1.2B4; MONOCLONAL ANTIBODY TS151; MONOCLONAL ANTIBODY TS151R; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; DISEASE SEVERITY; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; THROMBOCYTE AGGREGATION; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOTHERAPY; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN CONFORMATION;

EID: 79953214626     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390553     Document Type: Review

References (59)

1. Hemler, M.E. (2001) Specific tetraspanin functions. J. Cell Biol. 155, 1103-1107
2. Charrin, S., Le Naour, F., Silvie, O., Milhiet, P.E., Boucheix, C. and Rubinstein, E. (2009) Lateral organization of membrane proteins: tetraspanins spin their web. Biochem. J. 420, 133-154
3. Berditchevski, F. (2001) Complexes of tetraspanins with integrins: more than meets the eye. J. Cell Sci. 114, 4143-4151
4. Boucheix, C. and Rubinstein, E. (2001) Tetraspanins. Cell. Mol. Life Sci. 58, 1189-1205
5. Ikeyama, S., Koyama, M., Yamaoko, M., Sasada, R. and Miyake, M. (1993) Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. Exp. Med. 177, 1231-1237
6. Ovalle, S., Gutiérrez-Lopez, M.D., Olmo, N., Turnay, J., Lizarbe, M.A., Majano, P., Molina-Jiménez, F., López-Cabrera, M., Yáñez-Mó, M., Sánchez-Madrid, F. and Cabañas, C. (2007) The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells. Int. J. Cancer 121, 2140-2152 (Pubitemid 47585592)
7. Radford, K.J., Mallesch, J. and Hersey, P. (1995) Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63. Int. J. Cancer 62, 631-635
8. Yang, X., Wei, L.L., Tang, C., Slack, R., Mueller, S. and Lippman, M.E. (2001) Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res. 61, 5284-5288 (Pubitemid 32681565)
9. Gesierich, S., Berezoskyi, I., Ryschich, E. and Zöller, M. (2006) Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res. 66, 7083-7094 (Pubitemid 44197685)
10. Kohno, M., Hasegawa, H., Miyake, M., Yamamoto, T. and Fujita, S. (2002) CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int. J. Cancer 97, 336-343 (Pubitemid 34049024)
11. Sincock, P.M., Maryhofer, G. and Ashman, L.K. (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and α5β1 integrin. J. Histochem. Cytochem. 45, 515-525 (Pubitemid 27175796)
12. Tokuhara, T., Hasegawa, H., Hattori, N., Ishida, H., Taki, T., Tachibana, S., Sasaki, S. and Miyake, M. (2001) Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin. Cancer Res. 7, 4109-4114
13. Hashida, H., Takabayashi, A., Tokuhara, T., Hattori, N., Taki, T., Hasegawa, H., Satoh, S., Kobayash,i, N., Yamaoka, Y. and Miyake, M. (2003) Clinical significance of transmembrane 4 superfamily in colon cancer. Br. J. Cancer 89, 158-167
14. Chien, C.W., Lin, S.C., Lai, Y.Y., Lin, B.W., Lin, S.C., Lee, J.C. and Tsai, S.J. (2008) Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin. Cancer Res. 14, 8043-8051
15. Ang, J., Lijovic, M., Ashman, L.K., Kan, K. and Frauman, A.G. (2004) CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator. Cancer Epidemiol. Biomarkers Prev. 13, 1717-1721
16. Gesierich, S., Paret, C., Hildebrand, D., Weitz, J., Zgraggen, K., Schmitz-Winnenthal, F.H., Horejsi, V., Yoshie, O., Herlyn, D., Ashman, L.K. and Zöller, M. (2005) Colocalization of the tetraspanins CO-029 and CD151 with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin. Cancer Res. 11, 2840-2852
17. Yang, X.H., Richardson, A.L., Torres-Arzayus, M.I., Zhou, P., Sharma, C., Kazarov, A., Andzelm, M.M., Strominger, J.L., Brown, M. and Hemler, M.E. (2008) CD151 accelerated breast cancer by regulating α6 integrin function, signalling, and molecular organization. Cancer Res. 68, 3204-3213
18. Sadej, R., Romanska, H., Baldwin, G., Gkirtzimanaki, K., Novitskaya, V., Filer, A.D., Krcova, Z., Kusinska, R., Ehrmann, J., Buckley, C.D. et al. (2009) CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol. Cancer Res. 7, 787-798
19. Ke, A.W., Shi, G.M., Zhou, J., Wu, F.Z., Ding, Z.B., Hu, M.Y., Xu, Y., Song, Z.J., Wang, Z.J., Wu, J.C. et al. (2008) Role of everexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49, 491-503
20. Yauch, R.L., Berditchevski, F., Harler, M.B., Reichner, J. and Hemler, M.E. (1998) Highly stoichiometric, stable, and specific association of integrin α3β1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol. Biol. Cell 9, 2751-2765
21. Lammerding, J., Kazarov, A.R., Huang, H., Lee, R.T. and Hemler, M.E. (2003) Tetraspanin CD151 regulates α6β1 integrin adhesion strengthening. Proc. Natl. Acad. Sci. U.S.A. 100, 7616-7621
22. Nishiuchi, R., Sanzen, N., Nada, S., Sumida, Y., Wada, Y., Okada, M., Takagi, J., Hasegawa, H. and Seikiguchi, K. (2005) Potentiation of the ligand-binding activity of integrin α3β1 via association with tetraspanin CD151. Proc. Natl. Acad. Sci. U.S.A. 102, 1939-1944
23. Yamada, M., Sumida, Y., Fujibayashi, A., Fukaguchi, K., Sanzen, N., Nishiuchi, R. and Seikiguchi, K. (2008) The tetraspanin CD151 regulates cell morphology and intracellular signalling on laminin-511. FEBS J. 275, 3335-3351 (Pubitemid 351813546)
24. Winterwood, N.E., Varzavand, A., Meland, M.N., Ashman, L.K. and Stipp, C.S. (2006) A critical role for tetraspanin CD151 in α3β1 and α6β4 integrin-dependent tumor cell functions on laminin-5. Mol. Biol. Cell 17, 2707-2721
25. Kazarov, A.R., Yang, X., Stipp, C.S., Sehgal, B. and Hemler, M.E. (2002) An extracellular site on tetraspanin CD151 determines α3 and α6 integrin-dependent cellular morphology. J. Cell Biol. 158, 1299-1309
26. Yauch, R.L. and Hemler, M.E. (2000) Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem. J. 351, 629-637
27. Zhang, X.A., Bontrager, A.L. and Hemler, M.E. (2001) Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific β1 integrins. J. Biol. Chem. 276, 25005-25013
28. Klosek, S.K., Nakashiro, K., Hara, S., Shintani, S., Hasegawa, H. and Hamakawa, H. (2005) CD151 forms a functional complex with c-Met in human salivary gland cancer cells. Biochem. Biophys. Res. Commun. 336, 408-416
29. Franco, M., Muratori, C., Corso, S., Tenaglia, E., Bertotti, A., Capparuccia, L., Trusolino, L., Comoglio, P.M. and Tamagnone, L. (2010) The tetraspanin CD151 is required for Met-dependent signalling and tumor cell growth. J. Biol. Chem. 285, 38756-38764
30. Sadej, R., Romanska, H., Kavanagh, D., Baldwin, G., Takahashi, T., Kalia, N. and Berditchevski, F. (2010) Tetraspanin CD151 regulates transforming growth factor β signaling: implication in tumor metastasis. Cancer Res. 70, 6059-6070
31. Yang, X.W., Flores, L.M., Li, Q., Zhou, P., Xu, F., Krop, I.E. and Hemler, M.E. (2010) Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res. 70, 2256-2263
32. Shigeta, M., Sanzen, N., Ozawa, M., Gu, J., Hasegawa, H. and Sekiguchi, K. (2003) CD151 regulates epithelial cell-cell adhesion through PKC- and Cdc42-dependent actin cytoskeletal reorganization. J. Cell Biol. 163, 165-176 (Pubitemid 37271443)
33. Chattopadhyay, N., Wang, Z., Ashman, L.K., Brady-Kalnay, S.M. and Kreidberg, J. (2003), α3β1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPμ expression and cell-cell adhesion 163, 1351-1362
34. Johnson, J.L., Winterwood, N., DeMali, K.A. and Stipp, C.S. (2009) Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts. J. Cell Sci. 122, 2263-2273
35. Oren, R., Takahashi, S., Doss, C., Levy, R. and Levy, S. (1990) TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10, 4007-4015
36. Buschbaum, D.J., Wahl, R.L., Normolle, D.P. and Kaminski, M.S. (1992) Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts. Cancer Res. 52, 6476-6481
37. Robak, T., Robak, P. and Smolenski, P. (2009) TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies. Curr. Opin. Invest. Drugs 10, 1383-1390
38. Ashman, L.K., Aylett, G.W., Mehrabani, P.A., Bendall, L.J., Niutta, S., Cambareri, A.C., Cole, S.R. and Berndt, M.C. (1991) The murine monoclonal antibody, 14A2.H1, identifies a novel platelet surface antigen. Br. J. Haematol. 79, 263-270
39. Roberts, J.J., Rodgers, S.E., Drury, J., Ashman, L.K. and Lloyd, J.V. (1995) Platelet activation induced by a murine monoclonal antibody directed against a novel tetraspan antigen. Br. J. Haematol. 89, 853-860
40. Fitter, S., Sincock, P.M., Jolliffe, C.N. and Ashman, L.K. (1999) Transmembrane 4 superfamily protein CD151 (PETA-3) associates with β1 and αIIbβ3 integrins in haemopoeitic cell lines and modulates cell-cell adhesion. Biochem. J. 338, 61-70 (Pubitemid 29097286)
41. Serru, V., Le Naour, F., Billard, M., Azorsa, D.O., Lanza, F., Boucheix, C. and Rubinstein, E. (1999) Selective tetraspan-integrin complexes (CD81/α4β1, CD151/α3β1, CD151/α6β1) under conditions disrupting tetraspan interactions. Biochem. J. 340, 103-111 (Pubitemid 29251096)
42. Charrin, S., Le Naour, F., Oualid, M., Billard, M., Faure, G., Hanash, S.M., Boucheix, C. and Rubinstein, E. (2001) The major CD9 and CD81 molecular partner: identification and characterization of the complexes. J. Biol. Chem. 276, 14329-14337
43. Testa, J.E., Brooks, P.C., Lin, J.M. and Quigley, J.P. (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res. 59, 3812-3820 (Pubitemid 29381891)
44. Zijlstra, A., Lewis, J., DeGryse, B., Stuhlmann, H. and Quigley, J.P. (2008) The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13, 221-234 (Pubitemid 351318371)
45. Geary, S.M., Cambareri, A.C., Sincock, P.M., Fitter, S. and Ashman, L.K. (2001) Differential tissue expression of epitopes of the tetraspanin CD151 recognised by monoclonal antibodies. Tissue Antigens 58, 141-153 (Pubitemid 33078144)
46. Yamada, M., Tamura, Y., Sanzen, N., Sato-Nishiuchi, R., Hasegawa, H., Ashman, L.K., Rubinstein, E., Yáñez-Mó, M., Sánchez-Madrid, F. and Sekiguchi, K. (2008) Probing the interaction of tetraspanin CD151 with integrin α3β1 using a panel of monoclonal antibodies with distinct reactivities toward the CD151-integrin α3β1 complex. Biochem. J. 415, 417-427
47. Haeuw, J.-F. (2009) Novel antibodies used to treat cancer. Int. Pat. WO/2009/136070
48. Wright, M.D., Geary, S.M., Fitter, S., Moseley, G.W., Lau, L.M., Sheng, K.C., Apostolopoulos, V., Stanley, E.G., Jackson, D.E. and Ashman, L.K. (2004) Characterization of mice lacking the tetraspanin superfamily member CD151. Mol. Cell. Biol. 24, 5978-5988
49. Sachs, N., Kreft, M., Van Den Berg Weermann, M.A., Beynon, A.J., Peters, T.A., Weening, J.J. and Sonnenberg, A. (2006) Kidney failure in mice lacking the tetraspanin CD151. J. Cell Biol. 175, 33-39
50. Baleato, R.M., Guthrie, P.L., Gubler, M.C., Ashman, L.K. and Roselli, S. (2008) Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane. Am. J. Pathol. 173, 927-937
51. Ang, J., Fang, B.-L., Ashman, L.K. and Frauman, A.G. (2010) The migration and invasion of human prostate cell lines involves CD151 expression. Oncol. Rep. 24, 1593-1597
52. Klosek, S.K., Nakashiro, K., Hara, S., Goda, H., Hasegawa, H. and Hamakawa, H. (2005) CD151 regulates HGF-stimulated morphogenesis of human breast cancer cells. Biochem. Biophys. Res. Commun. 379, 1097-1100
53. Perrais, M., Chen, X., Perez-Moreno, M. and Gumbiner, B.M. (2007) E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol. Biol. Cell 18, 2013-2025
54. Asnaghi, L., Vass, W.C., Quadri, R., Day, P.M., Qian, X., Braverman, R., Papageorge, A.G. and Lowy, D.R. (2010) E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene 29, 2760-2771
55. Müller, E.J., Williamson, L., Kolly, C. and Suter, M.M. (2008) Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J. Invest. Dermatol. 128, 501-516
56. Takeda, Y., Kazarov, A., Butterfield, C.E., Hopkins, B.D., Benjamin, L.E., Kaipainen, A. and Hemler, M.E. (2007) Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109, 1524-1532 (Pubitemid 46239585)
57. Kubota, T., Niwa, R., Satoh, M., Akinaga, S., Shitara, K. and Hanai, N. (2008) Engineered therapeutic antibodies with improved effector functions. Cancer Sci. 100, 1566-1572
58. Karamatic-Crew, V., Burton, N., Kagan, A., Green, C.A., Levene, C., Flinter, F., Brady, R.L., Daniels, G. and Anstee, D.J. (2004) CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes is essential for the correct assembly of human basement membranes in kidney and skin. Blood 104, 2217-2223 (Pubitemid 39331816)
59. Committee for Medicinal Products for Human Use (CHMP) (2007) Guideline on Requirements for First-in-Man Clinical Trials for Potential High-Risk Medicinal Products, European Medicines Agency, London